New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023New Data Showing that Transgene and NEC’s TG4050 induces strong and specific immune responses against tumors presented at AACR15